SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,685,802 | -25.0% | 485,822 | +0.6% | 0.00% | – |
| Q2 2023 | $2,246,285 | +6.9% | 483,072 | +6.2% | 0.00% | – |
| Q1 2023 | $2,101,671 | -43.5% | 454,907 | -1.2% | 0.00% | -100.0% |
| Q4 2022 | $3,721,349 | +64.8% | 460,563 | +13.2% | 0.00% | 0.0% |
| Q3 2022 | $2,258,000 | +15.0% | 406,772 | +7.9% | 0.00% | – |
| Q2 2022 | $1,964,000 | -38.9% | 376,980 | -3.6% | 0.00% | -100.0% |
| Q1 2022 | $3,214,000 | -60.4% | 391,024 | -28.3% | 0.00% | 0.0% |
| Q4 2021 | $8,112,000 | -19.9% | 545,224 | +1.7% | 0.00% | -50.0% |
| Q3 2021 | $10,126,000 | -1.7% | 536,024 | -3.3% | 0.00% | 0.0% |
| Q2 2021 | $10,306,000 | +31.5% | 554,399 | +61.0% | 0.00% | +100.0% |
| Q1 2021 | $7,837,000 | +14.9% | 344,321 | +9.6% | 0.00% | 0.0% |
| Q4 2020 | $6,822,000 | +207.4% | 314,276 | +42.3% | 0.00% | – |
| Q3 2020 | $2,219,000 | +30.5% | 220,809 | +0.8% | 0.00% | – |
| Q2 2020 | $1,701,000 | +30.6% | 219,150 | +71.6% | 0.00% | – |
| Q1 2020 | $1,302,000 | -3.1% | 127,682 | +4.5% | 0.00% | – |
| Q4 2019 | $1,344,000 | +21.8% | 122,180 | +0.6% | 0.00% | – |
| Q3 2019 | $1,103,000 | +21.6% | 121,424 | +52.2% | 0.00% | – |
| Q2 2019 | $907,000 | +6.5% | 79,777 | +6.6% | 0.00% | – |
| Q1 2019 | $852,000 | +46.9% | 74,867 | +16.4% | 0.00% | – |
| Q4 2018 | $580,000 | – | 64,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |